查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球臨床微生物學市場（按產品、治療領域、最終用戶和地區分類）- 預測至 2030 年
市場調查報告書
商品編碼
1819089

全球臨床微生物學市場（按產品、治療領域、最終用戶和地區分類）- 預測至 2030 年

Clinical Microbiology Market by Product (Instrument, Analyzer, Reagent, Kits, Media), Disease Area, End User - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 411 Pages | 訂單完成後即時交付

價格

預計到 2030 年臨床微生物學市場規模將達到 73.4 億美元，預測期內複合年成長率為 6.6%。

調查範圍
調查年份 2024-2030
基準年 2024
預測期 2025-2030
對價單位 金額（十億美元）
部分 按產品、依疾病領域、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

臨床微生物學市場正經歷強勁成長，這得益於快速分子檢測和實驗室自動化等診斷技術的進步，這些技術能夠快速且準確地檢測傳染源。此外，由於人口成長、都市化和國際旅行增多，全球感染疾病負擔日益加重，進一步刺激了對先進微生物學檢測解決方案的需求。

臨床微生物學市場-IMG1

臨床微生物學市場細分為儀器、試劑以及培養基和血清。儀器佔據了最大的市場。這種主導地位歸因於多種因素，包括研究人員和學術機構廣泛採用傳統實驗室儀器，以及基因組學研究領域產學合作的日益加強。此外，微流體技術和蛋白質體學的進步，例如微流體技術與PCR的整合以及奈米技術在定量PCR中的應用，也正在推動市場的成長。

根據最終用戶，市場細分為醫院和診斷中心、合約實驗室以及學術和研究機構。預計到2024年，醫院和診斷中心市場將佔據最大市場佔有率，這得益於醫院機構數量的增加、研發活動向診斷中心外包的增加、慢性病負擔的增加以及醫院投資先進醫療基礎設施的能力。

全球臨床微生物學市場細分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。預計亞太地區將在預測期內實現最高成長率。該地區的新興經濟體GDP穩定成長，可支配收入顯著增加，從而導致各年齡層的醫療保健支出增加。其他成長動力包括感染疾病率和盛行率的上升、醫療基礎設施的現代化以及先進診斷技術的日益普及，尤其是在農村地區。這些因素預計將為亞太地區的臨床微生物學相關企業提供巨大的成長機會。

本報告研究了全球臨床微生物學市場，按產品、疾病領域、最終用戶和地區進行細分，並介紹了參與該市場的公司。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章重要考察

第5章 市場概況

  • 介紹
  • 市場動態
  • 定價分析
  • 專利分析
  • 價值鏈分析
  • 供應鏈分析
  • 貿易分析
  • 生態系分析
  • 波特五力分析
  • 監管狀況
  • 技術分析
  • 2025-2026年主要會議和活動
  • 影響客戶業務的趨勢/中斷
  • 主要相關人員和採購標準
  • 投資金籌措場景
  • 案例研究分析
  • 人工智慧/生成人工智慧對臨床微生物學市場的影響
  • 川普關稅對臨床微生物學市場的影響

第6章臨床微生物學市場（按產品）

  • 介紹
  • 裝置
  • 試劑
  • 培養基和血清

第7章臨床微生物學市場（依疾病領域）

  • 介紹
  • 呼吸系統疾病
  • 血流感染疾病
  • 消化系統疾病
  • 性行為感染傳染病
  • 尿道感染
  • 牙周病
  • 其他

8. 臨床微生物學市場（依最終用戶）

  • 介紹
  • 醫院和診斷中心
  • 合約測試組織
  • 學術研究機構

第9章臨床微生物學市場（按地區）

  • 介紹
  • 北美洲
    • 北美：宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：宏觀經濟展望
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太地區：宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲
    • 拉丁美洲：宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東與非洲：宏觀經濟展望
    • 沙烏地阿拉伯王國（KSA）
    • 阿拉伯聯合大公國（UAE）
    • 其他

第10章 競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 收益佔有率分析
  • 2024年市佔率分析
  • 公司估值矩陣：2024 年關鍵參與企業
  • 公司估值矩陣：Start-Ups/中小企業，2024 年
  • 估值和財務指標
  • 品牌/產品比較
  • 競爭場景

第11章 公司簡介

  • 主要參與企業
    • BIOMERIEUX
    • DANAHER CORPORATION
    • BECTON, DICKINSON AND COMPANY（BD）
    • THERMO FISHER SCIENTIFIC INC.
    • F. HOFFMANN-LA ROCHE LTD.
    • ABBOTT LABORATORIES
    • AGILENT TECHNOLOGIES, INC.
    • BRUKER CORPORATION
    • HOLOGIC, INC.
    • MERCK KGAA
    • BIO-RAD LABORATORIES, INC.
    • QIAGEN
    • SIEMENS HEALTHINEERS AG
  • 其他公司
    • SHIMADZU CORPORATION
    • NEOGEN CORPORATION
    • SEEGENE INC.
    • RAPID MICRO BIOSYSTEMS, INC.
    • HARDY DIAGNOSTICS
    • EMSL ANALYTICAL, INC.
    • LIOFILCHEM SRL
    • TCS BIOSCIENCES LTD.
    • MEMMERT GMBH+CO.KG
    • VACUTEST KIMA SRL
    • CREATIVE DIAGNOSTICS
    • DCN DX

第12章 附錄

Product Code: MD 3092

The clinical microbiology market is projected to reach USD 7.34 billion by 2030, growing at a CAGR of 6.6% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Disease Area, and End User
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

The clinical microbiology market is witnessing strong growth, driven by advancements in diagnostic technologies such as rapid molecular testing and laboratory automation, which enable faster & accurate detection of infectious agents. In addition, the rising global burden of infectious diseases, fueled by population growth, urbanization, and increased international travel, further accelerates the demand for advanced microbiology testing solutions.

Clinical Microbiology Market - IMG1

By product, the instruments segment accounted for the largest market share in 2024.

The clinical microbiology market is segmented into instruments, reagents, and media & sera. The instruments segment accounted for the largest share of the market. This dominance is driven by several factors, including the widespread adoption of conventional laboratory instruments by researchers & academic institutions, alongside increasing industry-academia collaborations in genomic research. Additionally, molecular techniques and proteomics advancements, such as integrating microfluidics with PCR and applying nanotechnology to qPCR, are fuelling the growth.

By end user, the hospitals & diagnostic centers segment accounted for the largest share of the market in 2024.

The market is segmented by end user into hospitals & diagnostic centers, contract testing laboratories, and academic & research institutes. In 2024, the hospitals & diagnostic laboratories segment accounted for the largest market share owing to the rising establishment of hospitals, the increasing outsourcing of R&D activities to diagnostic laboratories, the increasing burden of chronic diseases, and the ability of hospitals to invest in advanced healthcare infrastructure.

Asia Pacific is projected to grow at the highest CAGR during the forecast period.

The global clinical microbiology market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest growth rate during the forecast period. Emerging economies in this region are seeing consistent GDP growth and a notable rise in disposable income, contributing to increased healthcare spending across a broader population base. Additional growth drivers include the rising incidence and prevalence of infectious diseases, the modernization of healthcare infrastructure, and the growing adoption of advanced diagnostic technologies, particularly in rural areas. These factors are anticipated to create substantial growth opportunities for clinical microbiology companies in the Asia Pacific.

The break-up of the profile of primary participants in the clinical microbiology market:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and the Middle East & Africa- 4%

The key players in this market are bioMerieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Agilent Technologies, Inc. (US), Bruker Corporation (US), Hologic, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), Siemens Healthineers AG (Germany), Shimadzu Corporation (Japan), and Neogen Corporation (US), among others.

Research Coverage:

This research report categorizes the clinical microbiology market by product (instruments, reagents, and media & sera), by disease area (respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other diseases), by end user (hospitals & diagnostic centers, contract testing laboratories, and academic & research institutes), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

Reasons To Buy This Report:

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall clinical microbiology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (technological advancements in clinical diagnosis and novel molecular diagnostic-based instruments, rising incidence of infectious diseases and epidemics, increasing R&D programs and public-private investments), opportunities (improved healthcare infrastructure in emerging countries), restraints (limited reimbursement policies for clinical microbiology testing procedures), and challenges (operational barriers to diagnostic microbiology tests in emerging countries) influencing the growth of the clinical microbiology market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the clinical microbiology market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the clinical microbiology market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the clinical microbiology market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like bioMerieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), and F. Hoffmann-La Roche Ltd. (Switzerland), among others, in the clinical microbiology market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS & REGIONS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 KEY STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key secondary sources
      • 2.2.1.2 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL MICROBIOLOGY MARKET OVERVIEW
  • 4.2 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • 4.3 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2025 VS. 2030 (USD MILLION)
  • 4.4 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • 4.5 CLINICAL MICROBIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Technological advancements and development of novel molecular diagnostic-based instruments
      • 5.2.1.2 Rising incidence of infectious diseases and epidemics
      • 5.2.1.3 Increasing focus on R&D programs and public-private investments
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Limited reimbursement policies for clinical microbiology testing procedures
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Improved healthcare infrastructure in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Operational barriers for diagnostic microbiology tests
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS
    • 5.3.2 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY TEST KITS, BY KEY PLAYER, 2023-2025
    • 5.3.3 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS, BY REGION, 2023-2025
  • 5.4 PATENT ANALYSIS
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE ANALYSIS FOR OPTICAL MICROSCOPES
    • 5.7.2 IMPORT DATA (HS CODE 9011)
    • 5.7.3 EXPORT DATA (HS CODE 9011)
  • 5.8 ECOSYSTEM ANALYSIS
    • 5.8.1 CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 REGULATORY FRAMEWORK
      • 5.10.1.1 North America
        • 5.10.1.1.1 US
        • 5.10.1.1.2 Canada
      • 5.10.1.2 Europe
        • 5.10.1.2.1 Germany
        • 5.10.1.2.2 UK
        • 5.10.1.2.3 France
        • 5.10.1.2.4 Italy
      • 5.10.1.3 Asia Pacific
        • 5.10.1.3.1 China
        • 5.10.1.3.2 Japan
        • 5.10.1.3.3 India
      • 5.10.1.4 Latin America
        • 5.10.1.4.1 Brazil
        • 5.10.1.4.2 Mexico
      • 5.10.1.5 Middle East
        • 5.10.1.5.1 Africa
    • 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGIES
      • 5.11.1.1 MALDI-TOF mass spectrometry
    • 5.11.2 COMPLEMENTARY TECHNOLOGIES
      • 5.11.2.1 Optical immunosensors
      • 5.11.2.2 Electrochemical immunosensors
    • 5.11.3 ADJACENT TECHNOLOGIES
      • 5.11.3.1 Automated multiplex PCR systems
  • 5.12 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.14.2 BUYING CRITERIA
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 CASE STUDY 1: IMPACT OF MALDI-TOF MS AND RAPID SUSCEPTIBILITY TESTING ON SEPSIS MANAGEMENT
    • 5.16.2 CASE STUDY 2: IMPACT OF MULTIPLEX PCR PANELS IN MANAGING ACUTE GASTROENTERITIS IN ED
  • 5.17 IMPACT OF AI/GENERATIVE AI IN CLINICAL MICROBIOLOGY MARKET
    • 5.17.1 INTRODUCTION
    • 5.17.2 MARKET POTENTIAL OF AI
    • 5.17.3 AI-USE CASES
    • 5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY & CASE
    • 5.17.5 FUTURE OF AI IN CLINICAL MICROBIOLOGY MARKET
  • 5.18 TRUMP TARIFF IMPACT ON CLINICAL MICROBIOLOGY MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 KEY TARIFF RATES
    • 5.18.3 PRICE IMPACT ANALYSIS
    • 5.18.4 KEY IMPACT ON COUNTRY/REGION
      • 5.18.4.1 North America
      • 5.18.4.2 Europe
      • 5.18.4.3 Asia Pacific
    • 5.18.5 IMPACT ON END-USE INDUSTRIES
      • 5.18.5.1 Hospitals & diagnostic centers
      • 5.18.5.2 Contract testing laboratories
      • 5.18.5.3 Academic & research institutes

6 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 INSTRUMENTS
    • 6.2.1 LABORATORY INSTRUMENTS
      • 6.2.1.1 Incubators
        • 6.2.1.1.1 Rising demand for cell culture applications to drive market
      • 6.2.1.2 Gram stainers
        • 6.2.1.2.1 Rapid, accurate screening of bacterial pathogens to fuel uptake
      • 6.2.1.3 Bacterial colony counters
        • 6.2.1.3.1 Increased focus on accurate bacterial quantification to drive market
      • 6.2.1.4 Autoclave sterilizers
        • 6.2.1.4.1 Increasing focus on infection control in healthcare facilities to support market growth
      • 6.2.1.5 Microbial air samplers
        • 6.2.1.5.1 Need for enhanced air quality monitoring in cleanrooms to accelerate segment growth
      • 6.2.1.6 Anaerobic culture systems
        • 6.2.1.6.1 Increased research on anaerobic microorganisms to boost segment growth
      • 6.2.1.7 Petri dish fillers
        • 6.2.1.7.1 Need for minimal bench space and effective control with graphical user interfaces to aid segment growth
      • 6.2.1.8 Blood culture systems
        • 6.2.1.8.1 Technological advancements in diagnostic testing to drive market
      • 6.2.1.9 Microbial culture systems
        • 6.2.1.9.1 Increase in biopharmaceutical research to augment segment growth
      • 6.2.1.10 Other laboratory instruments
    • 6.2.2 MICROBIOLOGY ANALYZERS
      • 6.2.2.1 Molecular diagnostic instruments
        • 6.2.2.1.1 Advancements in multiplexing techniques and high adoption of genomics-based analysis to aid market growth
      • 6.2.2.2 Microscopes
        • 6.2.2.2.1 Rising demand for high-resolution imaging to propel market
      • 6.2.2.3 Mass spectrometers
        • 6.2.2.3.1 Increased applications in proteomics & metabolomics to boost market
  • 6.3 REAGENTS
    • 6.3.1 PATHOGEN-SPECIFIC KITS
      • 6.3.1.1 Increasing private-public initiatives for research to support market growth
    • 6.3.2 GENERAL REAGENTS
      • 6.3.2.1 Rising demand for diagnostic tests for pathogen detection to propel segment growth
  • 6.4 MEDIA & SERA
    • 6.4.1 RISING DEMAND FOR STANDARDIZED CULTURE MEDIA FOR MICROBIOLOGICAL TESTING TO PROPEL MARKET

7 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA

  • 7.1 INTRODUCTION
  • 7.2 RESPIRATORY DISEASES
    • 7.2.1 EXPANSION OF RESPIRATORY DISEASE SURVEILLANCE PROGRAMS TO DRIVE MARKET
  • 7.3 BLOODSTREAM INFECTIONS
    • 7.3.1 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
  • 7.4 GASTROINTESTINAL DISEASES
    • 7.4.1 HIGH RISK OF FOOD- AND WATER-BORNE INFECTIONS TO AID MARKET
  • 7.5 SEXUALLY TRANSMITTED DISEASES
    • 7.5.1 INCREASING EMPHASIS ON EARLY & EFFECTIVE DISEASE DIAGNOSIS TO BOOST DEMAND
  • 7.6 URINARY TRACT INFECTIONS
    • 7.6.1 FOCUS ON PREVENTIVE CARE TO SUPPORT MARKET GROWTH
  • 7.7 PERIODONTAL DISEASES
    • 7.7.1 INCREASING R&D INITIATIVES TO STUDY MICROBE-INDUCED DISEASES TO FUEL MARKET
  • 7.8 OTHER DISEASES

8 CLINICAL MICROBIOLOGY MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & DIAGNOSTIC CENTERS
    • 8.2.1 INCREASING PATIENT VOLUME AND RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 8.3 CONTRACT TESTING LABORATORIES
    • 8.3.1 LOW-COST OUTSOURCING OF TESTING ACTIVITIES TO LABORATORIES TO PROPEL MARKET
  • 8.4 ACADEMIC & RESEARCH INSTITUTES
    • 8.4.1 EXPANSION OF RESEARCH INITIATIVES AND FAVORABLE FUNDING INVESTMENTS TO BOOST MARKET

9 CLINICAL MICROBIOLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 9.2.2 US
      • 9.2.2.1 Increasing prevalence of infectious diseases to drive market
    • 9.2.3 CANADA
      • 9.2.3.1 Supportive government initiatives and increased research funding to boost market
  • 9.3 EUROPE
    • 9.3.1 EUROPE: MACROECONOMIC OUTLOOK
    • 9.3.2 GERMANY
      • 9.3.2.1 Favorable government policies to propel market
    • 9.3.3 FRANCE
      • 9.3.3.1 Favorable healthcare reforms and investments in diagnostic infrastructure to drive market
    • 9.3.4 UK
      • 9.3.4.1 Rising acceptance of genome-based diagnostic techniques to fuel market
    • 9.3.5 ITALY
      • 9.3.5.1 Improved healthcare services and better disease surveillance to support market growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Growing focus on public healthcare initiatives to augment market growth
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing government focus on disease prevention to drive market
    • 9.4.3 JAPAN
      • 9.4.3.1 Technological advancements in diagnostic kits to fuel uptake
    • 9.4.4 INDIA
      • 9.4.4.1 High target patient population to boost demand
    • 9.4.5 SOUTH KOREA
      • 9.4.5.1 Favorable government initiatives for medical tourism to support market growth
    • 9.4.6 AUSTRALIA
      • 9.4.6.1 Favorable healthcare automation techniques to support market growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 9.5.2 BRAZIL
      • 9.5.2.1 Universal healthcare access to drive market
    • 9.5.3 MEXICO
      • 9.5.3.1 Increasing prevalence of HIV to drive market
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    • 9.6.2 KINGDOM OF SAUDI ARABIA (KSA)
      • 9.6.2.1 Increasing focus on healthcare automation to drive market
    • 9.6.3 UNITED ARAB EMIRATES (UAE)
      • 9.6.3.1 Improvements in healthcare infrastructure to support market growth
    • 9.6.4 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET
  • 10.3 REVENUE SHARE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product footprint
      • 10.5.5.4 Instruments footprint
      • 10.5.5.5 Disease area footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of startups/SMEs (1/2)
      • 10.6.5.3 Competitive benchmarking of startups/SMEs (2/2)
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
    • 10.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 BIOMERIEUX
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products/Services offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product/Service launches & approvals
        • 11.1.1.3.2 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Key strengths
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 DANAHER CORPORATION
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products/Services offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product/Service launches & approvals
        • 11.1.2.3.2 Deals
        • 11.1.2.3.3 Expansions
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Key strengths
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 BECTON, DICKINSON AND COMPANY (BD)
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products/Services offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product/Service launches & approvals
        • 11.1.3.3.2 Deals
        • 11.1.3.3.3 Expansions
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Key strengths
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 THERMO FISHER SCIENTIFIC INC.
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products/Services offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product/Service launches & approvals
        • 11.1.4.3.2 Deals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Key strengths
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 F. HOFFMANN-LA ROCHE LTD.
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products/Services offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product/Service launches & approvals
        • 11.1.5.3.2 Deals
        • 11.1.5.3.3 Expansions
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Key strengths
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 ABBOTT LABORATORIES
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products/Services offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Deals
    • 11.1.7 AGILENT TECHNOLOGIES, INC.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products/Services offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Expansions
    • 11.1.8 BRUKER CORPORATION
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products/Services offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product/Service launches & approvals
        • 11.1.8.3.2 Deals
    • 11.1.9 HOLOGIC, INC.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products/Services offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product/Service launches & approvals
        • 11.1.9.3.2 Deals
    • 11.1.10 MERCK KGAA
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products/Services offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Deals
        • 11.1.10.3.2 Expansions
    • 11.1.11 BIO-RAD LABORATORIES, INC.
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products/Services offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Deals
    • 11.1.12 QIAGEN
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products/Services offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Product/Service launches
        • 11.1.12.3.2 Deals
        • 11.1.12.3.3 Expansions
    • 11.1.13 SIEMENS HEALTHINEERS AG
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products/Services offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product/Service launches
        • 11.1.13.3.2 Deals
        • 11.1.13.3.3 Expansions
  • 11.2 OTHER PLAYERS
    • 11.2.1 SHIMADZU CORPORATION
    • 11.2.2 NEOGEN CORPORATION
    • 11.2.3 SEEGENE INC.
    • 11.2.4 RAPID MICRO BIOSYSTEMS, INC.
    • 11.2.5 HARDY DIAGNOSTICS
    • 11.2.6 EMSL ANALYTICAL, INC.
    • 11.2.7 LIOFILCHEM S.R.L.
    • 11.2.8 TCS BIOSCIENCES LTD.
    • 11.2.9 MEMMERT GMBH + CO.KG
    • 11.2.10 VACUTEST KIMA S.R.L
    • 11.2.11 CREATIVE DIAGNOSTICS
    • 11.2.12 DCN DX

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 CLINICAL MICROBIOLOGY MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 CLINICAL MICROBIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 3 CLINICAL MICROBIOLOGY MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 AVERAGE SELLING PRICING TREND OF CLINICAL MICROBIOLOGY PRODUCTS, 2023-2025
  • TABLE 5 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY TEST KITS & ASSAYS, BY KEY PLAYER, 2023-2025
  • TABLE 6 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS, BY REGION, 2023-2025
  • TABLE 7 LIST OF MAJOR PATENTS, 2023-2025
  • TABLE 8 IMPORT DATA FOR OPTICAL MICROSCOPES (HS CODE 9011), BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 9 EXPORT DATA FOR OPTICAL MICROSCOPES (HS CODE 3822), BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 10 CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM
  • TABLE 12 CLASSIFICATION OF IVD DEVICES IN EUROPE
  • TABLE 13 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
  • TABLE 16 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CLINICAL MICROBIOLOGY PRODUCTS (%)
  • TABLE 21 KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS
  • TABLE 22 KEY COMPANIES IMPLEMENTING AI
  • TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 24 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 25 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 26 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 32 CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 33 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 39 CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 40 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 45 CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 69 CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 75 CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 81 CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 83 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 94 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 95 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 LIST OF COMMERCIALLY AVAILABLE MICROBIOLOGY ANALYZERS, 2023-2025
  • TABLE 100 CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 101 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 102 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 109 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 111 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 114 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 120 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 121 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 123 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 126 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 127 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 129 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 132 CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 133 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 134 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 136 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 137 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 138 CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 139 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 140 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 142 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 143 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 144 CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 145 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 146 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 148 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 150 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 151 GLOBAL NUMBER OF NEWLY DIAGNOSED TUBERCULOSIS (TB) CASES, 2023-2030 (IN MILLION)
  • TABLE 152 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 153 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 154 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 156 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 157 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 158 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 159 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 160 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 162 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 163 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 164 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 165 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 166 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 168 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 170 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 171 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 172 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 174 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 176 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 177 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 178 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 180 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 181 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 182 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 183 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 184 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 187 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 188 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 189 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 190 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 193 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 194 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 195 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 196 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 197 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 199 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 200 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 201 CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 202 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 203 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 206 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 207 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 208 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 209 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 211 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 212 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 213 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 214 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 215 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 216 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 217 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 218 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 219 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 220 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 221 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 222 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 223 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 224 US: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 US: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 US: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 US: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 228 US: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 229 US: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 230 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 231 CANADA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 CANADA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 CANADA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 234 CANADA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 235 CANADA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 236 CANADA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 237 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 238 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 239 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 242 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 243 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 244 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 245 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 246 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 247 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 249 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 251 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 252 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 253 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 254 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 258 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 259 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 260 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 261 UK: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 UK: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 263 UK: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 264 UK: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 265 UK: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 266 UK: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 267 ITALY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 268 ITALY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 269 ITALY: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 270 ITALY: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 271 ITALY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 272 ITALY: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 273 ITALY: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 274 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 275 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 276 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 278 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 279 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 280 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 281 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 282 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 284 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 285 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 286 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 287 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 288 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 289 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 290 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 291 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 297 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 298 CHINA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 299 CHINA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 300 CHINA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 301 CHINA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 302 CHINA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 303 CHINA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 304 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 305 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 306 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 307 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 308 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 309 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 310 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 311 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 312 INDIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 313 INDIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 314 INDIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 315 INDIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 316 INDIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 317 INDIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 318 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 319 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 320 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 321 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 322 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 323 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 324 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 325 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 326 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 327 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 328 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 329 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 330 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 331 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 332 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 333 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 334 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 335 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 336 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 337 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 338 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 339 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 340 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 341 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 342 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 343 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 344 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 345 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 346 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 347 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 348 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 349 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 350 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 351 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 352 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 353 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 354 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 355 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 356 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 357 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 358 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 359 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 360 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 361 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 362 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 363 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 364 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 365 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 366 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 367 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 368 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 369 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 370 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 371 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 372 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 373 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 374 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 375 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 376 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 377 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 378 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 379 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 380 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 381 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 382 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 383 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 384 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 385 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 386 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 387 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 388 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 389 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 390 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 391 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 392 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 393 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 394 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 395 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 396 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 397 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023-2030 (USD MILLION)
  • TABLE 398 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 399 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET, JANUARY 2021-AUGUST 2025
  • TABLE 400 CLINICAL MICROBIOLOGY MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • TABLE 401 CLINICAL MICROBIOLOGY MARKET: REGION FOOTPRINT
  • TABLE 402 CLINICAL MICROBIOLOGY MARKET: PRODUCT FOOTPRINT
  • TABLE 403 CLINICAL MICROBIOLOGY MARKET: INSTRUMENTS FOOTPRINT
  • TABLE 404 CLINICAL MICROBIOLOGY MARKET: DISEASE AREA FOOTPRINT
  • TABLE 405 CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 406 CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
  • TABLE 407 CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
  • TABLE 408 CLINICAL MICROBIOLOGY MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 409 CLINICAL MICROBIOLOGY MARKET: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 410 CLINICAL MICROBIOLOGY MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 411 BIOMERIEUX: COMPANY OVERVIEW
  • TABLE 412 BIOMERIEUX: PRODUCTS/SERVICES OFFERED
  • TABLE 413 BIOMERIEUX: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 414 BIOMERIEUX: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 415 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 416 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 417 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 418 DANAHER CORPORATION: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 419 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 420 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 421 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED
  • TABLE 422 BECTON, DICKINSON AND COMPANY: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 423 BECKTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 424 BECKTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021- AUGUST 2025
  • TABLE 425 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 426 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 427 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 428 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 429 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 430 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 431 F. HOFFMANN-LA ROCHE LTD.: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 432 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 433 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 434 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 435 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 436 ABBOTT LABORATORIES: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 438 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 439 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 440 BRUKER CORPORATION: COMPANY OVERVIEW
  • TABLE 441 BRUKER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 442 BRUKER CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021- AUGUST 2025
  • TABLE 443 BRUKER CORPORATION: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 444 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 445 HOLOGIC, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 446 HOLOGIC, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2025
  • TABLE 447 HOLOGIC, INC.: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 448 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 449 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 450 MERCK KGAA: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 451 MERCK KGAA: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 452 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 453 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 454 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 455 QIAGEN: COMPANY OVERVIEW
  • TABLE 456 QIAGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 457 QIAGEN: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2025
  • TABLE 458 QIAGEN: DEALS, JANUARY 2021-AUGUST 2025
  • TABLE 459 QIAGEN: EXPANSIONS, JANUARY 2021-AUGUST 2025
  • TABLE 460 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 461 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED
  • TABLE 462 SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2025
  • TABLE 463 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021- AUGUST 2025
  • TABLE 464 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021- AUGUST 2025
  • TABLE 465 SHIMADZU CORPORATION: COMPANY OVERVIEW
  • TABLE 466 NEOGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 467 SEEGENE INC.: COMPANY OVERVIEW
  • TABLE 468 RAPID MICRO BIOSYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 469 HARDY DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 470 EMSL ANALYTICAL, INC.: COMPANY OVERVIEW
  • TABLE 471 LIOFILCHEM S.R.L.: COMPANY OVERVIEW
  • TABLE 472 TCS BIOSCIENCES LTD.: COMPANY OVERVIEW
  • TABLE 473 MEMMERT GMBH + CO.KG: COMPANY OVERVIEW
  • TABLE 474 VACUTEST KIMA S.R.L: COMPANY OVERVIEW
  • TABLE 475 CREATIVE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 476 DCN DX: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 CLINICAL MICROBIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 CLINICAL MICROBIOLOGY MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY & DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 8 CLINICAL MICROBIOLOGY MARKET: TOP-DOWN APPROACH
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 CLINICAL MICROBIOLOGY MARKET: RESEARCH ASSUMPTIONS
  • FIGURE 11 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 HIGH PREVALENCE OF INFECTIOUS DISEASES AND TECHNOLOGICAL ADVANCEMENTS IN NOVEL DIAGNOSTICS TO DRIVE MARKET
  • FIGURE 16 INSTRUMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 17 RESPIRATORY DISEASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 18 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 19 ASIA PACIFIC REGION TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 20 CLINICAL MICROBIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21 PATENT ANALYSIS FOR CLINICAL MICROBIOLOGY (JANUARY 2015-DECEMBER 2024)
  • FIGURE 22 VALUE CHAIN ANALYSIS OF CLINICAL MICROBIOLOGY MARKET: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
  • FIGURE 23 CLINICAL MICROBIOLOGY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 24 CLINICAL MICROBIOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 25 CLINICAL MICROBIOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 26 CLINICAL MICROBIOLOGY MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CLINICAL MICROBIOLOGY PRODUCTS
  • FIGURE 28 KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS
  • FIGURE 29 NUMBER OF DEALS & FUNDING ACTIVITIES IN CLINICAL MICROBIOLOGY MARKET (2021-2024)
  • FIGURE 30 MARKET POTENTIAL OF AI IN CLINICAL MICROBIOLOGY MARKET
  • FIGURE 31 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET (2022-2024)
  • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET (2024)
  • FIGURE 35 CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 36 CLINICAL MICROBIOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 37 CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 38 EV/EBITDA OF KEY VENDORS
  • FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 40 CLINICAL MICROBIOLOGY MARKET: BRAND COMPARISON FOR INSTRUMENTS
  • FIGURE 41 BIOMERIEUX: COMPANY SNAPSHOT (2024)
  • FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
  • FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
  • FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 49 HOLOGIC, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2024)
  • FIGURE 53 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)